Ancarolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00EED65INL, chemically known as (r,s)-2-(3-(tert-butylamino)-2-hydroxypropoxy-2-furanilid but generally known as ancarolol, which bears US NIH Compound Identifier 170339. European Medicines Agency schedules Ancarolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05506MIG. The term ANCAROLOL is an International Non-Proprietary Name. ANCAROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ancarolol under HS 29321900 and SITC 51569. As of Q4 2014, ANCAROLOL remains the US FDA Preferred Term for this commodity. Ancarolol bears US NLM identifiers UMLS ID C2346780 and NCI Concept Code C73014. SMILES: OC(CNC(C)(C)C)COC1C(NC(=O)C2OCCC2)CCCC1.